vs
Side-by-side financial comparison of PennyMac Mortgage Investment Trust (PMT) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $93.6M, roughly 1.8× PennyMac Mortgage Investment Trust). PennyMac Mortgage Investment Trust runs the higher net margin — 56.0% vs -82.0%, a 137.9% gap on every dollar of revenue. On growth, PennyMac Mortgage Investment Trust posted the faster year-over-year revenue change (-13.3% vs -22.7%). Over the past eight quarters, PennyMac Mortgage Investment Trust's revenue compounded faster (12.3% CAGR vs -11.5%).
PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PMT vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.6M | $164.7M |
| Net Profit | $52.4M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 38.6% | -43.3% |
| Net Margin | 56.0% | -82.0% |
| Revenue YoY | -13.3% | -22.7% |
| Net Profit YoY | 12.5% | -104.8% |
| EPS (diluted) | $0.49 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.6M | $164.7M | ||
| Q3 25 | $99.2M | $211.0M | ||
| Q2 25 | $70.2M | $178.9M | ||
| Q1 25 | $44.5M | $1.2B | ||
| Q4 24 | $107.9M | $213.2M | ||
| Q3 24 | $80.9M | $196.8M | ||
| Q2 24 | $71.2M | $186.7M | ||
| Q1 24 | $74.2M | $210.1M |
| Q4 25 | $52.4M | $-135.0M | ||
| Q3 25 | $58.3M | $15.9M | ||
| Q2 25 | $7.5M | $-64.8M | ||
| Q1 25 | $9.7M | $866.6M | ||
| Q4 24 | $46.5M | $-65.9M | ||
| Q3 24 | $41.4M | $-106.7M | ||
| Q2 24 | $25.4M | $-99.2M | ||
| Q1 24 | $47.6M | $-91.6M |
| Q4 25 | 38.6% | -43.3% | ||
| Q3 25 | 47.4% | 1.4% | ||
| Q2 25 | 24.2% | -19.5% | ||
| Q1 25 | -14.2% | 82.5% | ||
| Q4 24 | 51.1% | -76.2% | ||
| Q3 24 | 32.8% | -27.7% | ||
| Q2 24 | 40.2% | -21.5% | ||
| Q1 24 | 43.6% | -21.6% |
| Q4 25 | 56.0% | -82.0% | ||
| Q3 25 | 58.7% | 7.5% | ||
| Q2 25 | 10.7% | -36.3% | ||
| Q1 25 | 21.8% | 73.7% | ||
| Q4 24 | 43.1% | -30.9% | ||
| Q3 24 | 51.2% | -54.2% | ||
| Q2 24 | 35.7% | -53.1% | ||
| Q1 24 | 64.2% | -43.6% |
| Q4 25 | $0.49 | $-1.63 | ||
| Q3 25 | $0.55 | $0.20 | ||
| Q2 25 | $-0.04 | $-0.83 | ||
| Q1 25 | $-0.01 | $10.04 | ||
| Q4 24 | $0.45 | $-0.85 | ||
| Q3 24 | $0.36 | $-1.39 | ||
| Q2 24 | $0.17 | $-1.29 | ||
| Q1 24 | $0.39 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $190.5M | $1.9B |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $1.9B | $-205.3M |
| Total Assets | $21.3B | $2.9B |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $190.5M | $1.9B | ||
| Q3 25 | $181.0M | $1.7B | ||
| Q2 25 | $108.6M | $2.0B | ||
| Q1 25 | $204.2M | $2.0B | ||
| Q4 24 | $103.2M | $1.1B | ||
| Q3 24 | $102.8M | $1.0B | ||
| Q2 24 | $336.3M | $1.1B | ||
| Q1 24 | $343.3M | $884.8M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $299.0M | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $968.4M | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $5.4B | — | ||
| Q1 24 | $5.1B | — |
| Q4 25 | $1.9B | $-205.3M | ||
| Q3 25 | $1.9B | $-155.8M | ||
| Q2 25 | $1.9B | $-206.5M | ||
| Q1 25 | $1.9B | $-185.8M | ||
| Q4 24 | $1.9B | $-1.1B | ||
| Q3 24 | $1.9B | $-1.1B | ||
| Q2 24 | $1.9B | $-980.2M | ||
| Q1 24 | $2.0B | $-893.9M |
| Q4 25 | $21.3B | $2.9B | ||
| Q3 25 | $18.5B | $2.6B | ||
| Q2 25 | $16.8B | $2.6B | ||
| Q1 25 | $14.9B | $2.7B | ||
| Q4 24 | $14.4B | $1.7B | ||
| Q3 24 | $13.1B | $1.8B | ||
| Q2 24 | $12.1B | $1.9B | ||
| Q1 24 | $12.3B | $1.8B |
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 2.70× | — | ||
| Q2 24 | 2.76× | — | ||
| Q1 24 | 2.60× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.2B | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | -137.76× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.2B | $-34.3M | ||
| Q3 25 | $-1.3B | $-66.3M | ||
| Q2 25 | $-2.0B | $-58.3M | ||
| Q1 25 | $-594.3M | $870.1M | ||
| Q4 24 | $-2.7B | $-30.0M | ||
| Q3 24 | $-983.8M | $-77.0M | ||
| Q2 24 | $243.8M | $-71.5M | ||
| Q1 24 | $-342.4M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | -137.76× | — | ||
| Q3 25 | -22.26× | -4.17× | ||
| Q2 25 | -267.53× | — | ||
| Q1 25 | -61.39× | 1.00× | ||
| Q4 24 | -58.08× | — | ||
| Q3 24 | -23.76× | — | ||
| Q2 24 | 9.59× | — | ||
| Q1 24 | -7.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PMT
| Other | $55.0M | 59% |
| Interest Rate Sensitive Strategies | $31.4M | 34% |
| Correspondent Production | $7.2M | 8% |
PTCT
Segment breakdown not available.
